ClinMax? Human CCL5/RANTES ELISA Kit
產(chǎn)品概述（Product Details）
ClinMax? Human CCL5/RANTES ELISA Kit is a ready-to-use immunoassay kit, specifically designed to quantitate natural and recombinant human CCL5/RANTES that is present in biological samples, such as human serum, plasma, and cell culture supernatants. Our
ClinMax? ELISA Kit provides several benefits:
Standards to calibrate with NIBSC/WHO standards for comparable results.
Fully validation in biologic samples for detection range, sensitivity, inter- and intra-plate CV, recovery, dilution linearity, specificity, and matrix effects to ensure reliable results according to ICH M10 guideline.
High-quality antibody pairs and protein standards, along with rigorous quality control, to guarantee consistent results across different batches.
Simplified and straightforward protocols and ready-to-use reagents to save assay time.
應用說明（Application）
The kit is developed for quantitative detection of natural and recombinant human CCL5/RANTES in serum, plasma and cell culture supernatants.
It is for research use only.
流程圖（Workflow）
關鍵信息（Key Features）
Elevate your research experience with our Cytokine/Biomarker Detection Kits, where accuracy, reliability, and ease of use are converging to deliver exceptional results.
存儲（Storage）
Keep the unopened kit stored at 2-8 °C. Avoid using the kit beyond its expiration date. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.
關鍵字： CCL5;CCL5試劑盒;CCL5 ELISA試劑盒;ACRO;百普賽斯;
百普賽斯集團ACROBiosystems Group（股票代碼：301080）是成立于2010年的跨國生物科技公司，是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領域提供關鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團業(yè)務遍布全球，橫跨亞洲、北美洲、歐洲，在中國、美國、瑞士等12個城市設有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計服務客戶超6000家，與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關系。集團旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學等。